Related Experiment Video
Updated: May 19, 2026
In Vitro Culture of Epicardial Cells From Mouse Embryonic Heart
Published on: April 27, 2016
Epicardial progenitor cells in cardiac regeneration and neovascularisation
Nicola Smart1, Karina N Dubé, Paul R Riley
1Department of Physiology, Anatomy and Genetics, University of Oxford, UK. nicola.smart@dpag.ox.ac.uk
Insights
Thymosin β4 (Tβ4) reactivates dormant epicardium-derived cells (EPDCs) in adult hearts. This promotes new blood vessel and cardiomyocyte formation, aiding repair after heart attacks.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Developmental Biology
Background:
- Cardiovascular diseases are a leading cause of global mortality and morbidity.
- The adult mammalian heart has limited regenerative capacity, increasing heart failure risk post-myocardial infarction.
- Understanding embryonic development and regeneration mechanisms is crucial for myocardial repair strategies.
Purpose of the Study:
- To investigate the potential of epicardium-derived cells (EPDCs) for myocardial and coronary vasculature repair.
- To identify molecular cues that can reactivate dormant EPDCs in adult hearts.
- To evaluate the therapeutic efficacy of Thymosin β4 (Tβ4) in promoting cardiac regeneration post-myocardial infarction.
Main Methods:
- Treatment of infarcted hearts with Thymosin β4 (Tβ4).
- Analysis of EPDC proliferation and differentiation.
- Assessment of new blood vessel formation (vasculogenesis) and cardiomyocyte generation.
- Evaluation of functional recovery and blood flow restoration in the ischaemic myocardium.
Main Results:
- Tβ4 treatment restored the quiescent adult epicardium to an embryonic pluripotent state.
- Significant EPDC proliferation and formation of a functional, perfused vascular network were observed.
- Tβ4 facilitated the generation of mature cardiomyocytes from epicardial sources, integrated with resident myocardium.
Conclusions:
- Thymosin β4 (Tβ4) is a key molecular cue that can stimulate cardiac regeneration by reactivating epicardium-derived cells (EPDCs).
- Tβ4 treatment promotes neovascularization and de novo cardiomyocyte formation, improving cardiac function post-myocardial infarction.
- EPDCs represent a promising cell population for therapeutic strategies aimed at heart repair and regeneration.
Abstract:
While cardiovascular diseases remain the major worldwide cause of mortality and morbidity, there is an urgent need to tackle the clinical and economic burden of heart failure. Since the mammalian heart is unable to adequately regenerate beyond early postnatal stages, individuals surviving acute myocardial infarction are at risk of heart failure. Understanding the embryonic mechanisms of vasculogenesis and cardiogenesis, as well as the mechanisms retained for regeneration in species such as the zebrafish, will inform on strategies for human myocardial repair. Due to their fundamental role in heart development, epicardium-derived cells (EPDCs) have emerged as a population with potential to restore myocardium and coronary vasculature. The ability to revive ordinarily dormant EPDCs lies in the identification of key molecular cues used in the embryo to orchestrate cardiovascular development. One such stimulatory factor, Thymosin β4 (Tβ4), restores the quiescent adult epicardium to its pluripotent embryonic state. Tβ4 treatment of infarcted hearts induces dramatic EPDC proliferation and formation of a network of perfused, functional vessels to enhance blood flow to the ischaemic myocardium. Moreover, Tβ4 facilitates an epicardial contribution of mature de novo cardiomyocytes, structurally and functionally coupled with resident myocardium, which may contribute towards the functional improvement of Tβ4-treated hearts post-MI.
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
01:12Renewal of Skin Epidermal Stem Cells